Benchmark Nifty index settled on a flat note, closed shop at 17893 levels after adding just 21 points to its previous closing values.
Global Market Update
News highlights from across the globe
Important news updates from the domestic front
Broader markets too settled on a flat note. Resultant, market breadth was flat as 1105 advances recorded against 1139 declines at NSE.
Performance on the sectoral front was mix. IT & Media index were at the top of the tally, gained at 0.70% & 0.60% respectively. On the other hand, Metal index leads the decline, ended lower by 1.58%.
Technically, Nifty index is trading on verge of bullish breakout from the congestion zone of 17600-17900 levels. Going ahead, crossover and sustenance above 17925 will open the doors for fresh up move up to 18100 and higher levels in immediate short term.
Derivatives Overview & Outlook
Yesterday, no significant activity was seen in Nifty & Banknifty futures on price front whereas on the open interest front both shed around 1% & 3% of open interest respectively.
On the sectoral front, long buildup was seen among Textile, Capital Goods and IT stocks whereas some short buildup was seen among Auto, Infra and Telecom stocks.
On options front, Nifty will start the new weekly contract with maximum positions at 17800 PE and 18000 CE.
FII & DII Trading Activity
Yesterday, FIIs sold stocks worth Rs 145 Cr in cash segment and also sold index futures worth Rs 104 Cr. DIIs were net sellers in the cash segment to the tune of Rs 205 Cr.
Nifty Futures & Bank Nifty Futures Key Levels
Nifty Futures – Resistances 18025-18100; Supports 17870-17750
Banknifty Futures – Resistances 41950-42250; Supports 41400-41200
Important Results Today
Mahindra & Mahindra, Bharat Heavy Electricals, Oil India, Glenmark Pharmaceuticals, National Aluminium Company, Alkem Laboratories, Delhivery, ABB India, Fortis Healthcare, JK Lakshmi Cement, Abbott India, Ashoka Buildcon, BEML, Indigo Paints, Indiabulls Real Estate, Inox Green Energy Services, Inox Wind, Rail Vikas Nigam, Religare Enterprises, Astra Microwave Products, AstraZeneca Pharma India
Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, USE and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.
Globe Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. Rolex Finvest Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited and Lakshya Impex Private Limited are associates of GCML. Globe Comex International DMCC is step down subsidiary of GCML.
This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.
Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.
This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.
Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months. GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.
Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months.
No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.
The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.
Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.